Abstract
Drug resistance is a major problem in cancer treatment, as it limits the effectiveness of pharmacological agents and can lead to disease progression. Cold atmospheric plasma (CAP) is a technology that uses ionized gas (plasma) to generate reactive oxygen and nitrogen species (RONS) that can kill cancer cells. CAP is a novel approach for overcoming drug resistance in cancer. In recent years, there has been a growing interest in using CAP to enhance the effectiveness of chemotherapy drugs. In this review, we discuss the mechanisms behind this phenomenon and explore its potential applications in cancer treatment. Going through the existing literature on CAP and drug resistance in cancer, we highlight the challenges and opportunities for further research in this field. Our review suggests that CAP could be a promising option for overcoming drug resistance in cancer and warrants further investigation.
Subject
General Biochemistry, Genetics and Molecular Biology,Medicine (miscellaneous)
Reference161 articles.
1. Challenges and Opportunities in Cancer Drug Resistance;Ward;Chem. Rev.,2021
2. A View on Drug Resistance in Cancer;Vasan;Nature,2019
3. Braný, D., Dvorská, D., Halašová, E., and Škovierová, H. (2020). Cold Atmospheric Plasma: A Powerful Tool for Modern Medicine. Int. J. Mol. Sci., 21.
4. Therapy Resistance: Opportunities Created by Adaptive Responses to Targeted Therapies in Cancer;Labrie;Nat. Rev. Cancer,2022
5. Differences in Growth Properties of Endometrial Cancer in Three Dimensional (3d) Culture and 2d Cell Monolayer;Chitcholtan;Exp. Cell Res.,2013
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献